Campbell LJ - Search Results

1

Sequential transformation of t(8;13)-related disease: a case report.

Roy S, Szer J, Campbell LJ, Juneja S. Roy S, et al. Among authors: campbell lj. Acta Haematol. 2002;107(2):95-7. doi: 10.1159/000046637. Acta Haematol. 2002. PMID: 11919389

2

Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy.

Seymour JF, Juneja SK, Campbell LJ, Ellims PH, Estey EH, Prince HM. Seymour JF, et al. Among authors: campbell lj. Leukemia. 1999 Nov;13(11):1735-40. doi: 10.1038/sj.leu.2401552. Leukemia. 1999. PMID: 10557046 Review.

3

Morphological effects of imatinib mesylate (STI571) on the bone marrow and blood of patients with Philadelphia chromosome (Ph) positive chronic myeloid leukaemia.

McNamara C, Grigg A, Szer J, Roberts A, Campbell L, Hoyt R, Lynch K, Juneja S. McNamara C, et al. Clin Lab Haematol. 2003 Apr;25(2):119-25. doi: 10.1046/j.1365-2257.2003.00497.x. Clin Lab Haematol. 2003. PMID: 12641616 Clinical Trial.

4

Application of interphase cytogenetics to monitor bone marrow transplants.

Vrazas V, Ooms LM, Rudduck C, Szer J, Campbell LJ, Garson OM. Vrazas V, et al. Among authors: campbell lj. Am J Hematol. 1995 May;49(1):15-20. doi: 10.1002/ajh.2830490104. Am J Hematol. 1995. PMID: 7741133

5

BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration.

Campbell LJ, Patsouris C, Rayeroux KC, Somana K, Januszewicz EH, Szer J. Campbell LJ, et al. Cancer Genet Cytogenet. 2002 Nov;139(1):30-3. doi: 10.1016/s0165-4608(02)00615-5. Cancer Genet Cytogenet. 2002. PMID: 12547154

6

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.

Iland HJ, Collins M, Bradstock K, Supple SG, Catalano A, Hertzberg M, Browett P, Grigg A, Firkin F, Campbell LJ, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Among authors: campbell lj. Lancet Haematol. 2015 Sep;2(9):e357-66. doi: 10.1016/S2352-3026(15)00115-5. Epub 2015 Aug 20. Lancet Haematol. 2015. PMID: 26685769 Clinical Trial.

7

Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia.

Huntly BJ, Reid AG, Bench AJ, Campbell LJ, Telford N, Shepherd P, Szer J, Prince HM, Turner P, Grace C, Nacheva EP, Green AR. Huntly BJ, et al. Among authors: campbell lj. Blood. 2001 Sep 15;98(6):1732-8. doi: 10.1182/blood.v98.6.1732. Blood. 2001. PMID: 11535505 Free article.

8

A new nonrandom unbalanced t(17;20) in myeloid malignancies.

Patsouris C, Michael PM, Campbell LJ. Patsouris C, et al. Among authors: campbell lj. Cancer Genet Cytogenet. 2002 Oct 1;138(1):32-7. doi: 10.1016/s0165-4608(02)00579-4. Cancer Genet Cytogenet. 2002. PMID: 12419582

9

Dawson MA, Schwarer AP, McLean C, Oei P, Campbell LJ, Wright E, Shortt J, Street AM. Dawson MA, et al. Among authors: campbell lj. Haematologica. 2007 Jan;92(1):e11-2. doi: 10.3324/haematol.10933. Haematologica. 2007. PMID: 17405744 Free article.

10

Three adults with acute lymphoblastic leukemia and dic(7;9)(p11.2;p11).

Smith A, Das P, O'Reilly J, Patsouris C, Campbell LJ. Smith A, et al. Among authors: campbell lj. Cancer Genet Cytogenet. 2006 Apr 1;166(1):86-8. doi: 10.1016/j.cancergencyto.2005.08.011. Cancer Genet Cytogenet. 2006. PMID: 16616116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page